These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17382809)

  • 41. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 42. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 43. Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.
    Wang Z
    Cornell Law Rev; 2014 Jul; 99(5):1227-58. PubMed ID: 25112001
    [No Abstract]   [Full Text] [Related]  

  • 44. Thailand and the compulsory licensing of efavirenz.
    Steinbrook R
    N Engl J Med; 2007 Feb; 356(6):544-6. PubMed ID: 17287474
    [No Abstract]   [Full Text] [Related]  

  • 45. Current development in regulation of similar biotherapeutic products in Brazil.
    Castanheira LG; Barbano DB; Rech N
    Biologicals; 2011 Sep; 39(5):308-11. PubMed ID: 21868247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
    Viana JM
    Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug importation and safety of drugs obtained from Canada.
    Shepherd M
    Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The new reference prices: an opportunity for efficient management of medication].
    Ausejo Segura M
    Aten Primaria; 2005 Feb; 35(2):64-6. PubMed ID: 15727746
    [No Abstract]   [Full Text] [Related]  

  • 49. Competition body rules that drug companies "abused" their position.
    Sidley P
    BMJ; 2003 Oct; 327(7421):946. PubMed ID: 14576226
    [No Abstract]   [Full Text] [Related]  

  • 50. India: access to affordable drugs and the right to health.
    Grover A; Citro B
    Lancet; 2011 Mar; 377(9770):976-7. PubMed ID: 21227487
    [No Abstract]   [Full Text] [Related]  

  • 51. Production of low cost AIDS drugs to continue in Brazil.
    Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
    [No Abstract]   [Full Text] [Related]  

  • 52. Less expensive ZDV on the way.
    AIDS Read; 2005 Nov; 15(11):573-4. PubMed ID: 16329175
    [No Abstract]   [Full Text] [Related]  

  • 53. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 54. The ongoing regulation of generic drugs.
    Frank RG
    N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956
    [No Abstract]   [Full Text] [Related]  

  • 55. Intellectual property. Drug patents at the Supreme Court.
    Hemphill CS; Sampat B
    Science; 2013 Mar; 339(6126):1386-7. PubMed ID: 23520096
    [No Abstract]   [Full Text] [Related]  

  • 56. Policy making on data exclusivity in the European Union: from industrial interests to legal realities.
    Adamini S; Maarse H; Versluis E; Light DW
    J Health Polit Policy Law; 2009 Dec; 34(6):979-1010. PubMed ID: 20018988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The financing and price regulation of drugs in the Spanish National Health System: changes and continuity].
    Puig-Junoy J
    Gac Sanit; 2007; 21(1):1-4. PubMed ID: 17306178
    [No Abstract]   [Full Text] [Related]  

  • 58. Debate on essential medicines heats up.
    Kapp C
    Lancet Infect Dis; 2001 Nov; 1(4):215. PubMed ID: 11871503
    [No Abstract]   [Full Text] [Related]  

  • 59. Legal tactics to delay launch of generic drugs cost Europe euro3bn, report says.
    Jack A
    BMJ; 2008 Dec; 337():a2817. PubMed ID: 19047187
    [No Abstract]   [Full Text] [Related]  

  • 60. Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1.
    AIDS Treat News; 1999 Jun; (No 321):8. PubMed ID: 11366716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.